Hubert Tsui

Dr. Hubert Tsui

Head, Division of Hematopathology, Hematopathologist, Sunnybrook Health Sciences Centre, Toronto

Biography

Hubert Tsui completed his MD, PhD in immunology and residency in hematological pathology at the University of Toronto. He is presently Head of the Division of Hematopathology, Department of Laboratory Medicine and Molecular Diagnostics at Sunnybrook Health Sciences Centre and Associate Scientist, Sunnybrook Research Institute after starting his career at the Toronto General Hospital, University Health Network in 2015. He holds the rank of Assistant Professor with the Department of Laboratory Medicine and Pathobiology and is cross-appointed to the Department of Immunology, Faculty of Medicine, University of Toronto. Dr. Tsui has co-authored 20 peer reviewed manuscripts and two textbook chapters, including top-tier journals such as Cell, Nature Medicine and Lancet. His graduate work on the neuroimmune pathogenesis of Type 1 diabetes formed the basis of his current research interests on the neuroimmune pathobiology of hematologic malignancies, with a particular focus on the interactions between the bone marrow niche and myeloproliferative neoplasms (MPN). Through his medical training, Dr. Tsui independently generated over $40,000 in research grants and has received various local, national and international awards including multiple ASH Abstract Achievement Awards, the Canadian Hematology Society John H. Crookston Award and fellowship funding from the Royal College of Physicians and Surgeons of Canada. He is one of the few Canadian alumni of the prestigious American Society of Hematology / European Hematology Association Translational Research Training in Hematology (ASH-EHA TRTH) program. Since becoming a staff hematopathologist, Dr. Tsui has received $300,000 in funding to pursue his ideas on novel immune and stromal cell biomarkers in MPN. He is presently funded by the OICR in collaboration with Dr. Vikas Gupta (UHN) on a project entitled: Bone Marrow Derived Proteogenomic Immune-Stromal Cell Signatures Reveal Niche Heterogeneity in Primary Myelofibrosis – Impact on Response to JAK Inhibition. Dr. Tsui’s career plans include continued development as a clinician– translational research scientist coinciding with the expansion of complex malignant hematology at Sunnybrook Health Sciences Centre.

Funded Projects

Bone Marrow Derived Proteogenomic Immune-Stromal Cell Signatures Reveal Niche Heterogeneity in Primary Myelofibrosis - Impact on Response to JAK Inhibition »



Research Specialties

Research Interests

  • Hematological

Contact for Collaboration

Sunnybrook Health Sciences Centre
Toronto
Pathologists and Researchers who are interested in being part of the OMPRN: